Vancouver, British Columbia and Rehovot, Israel — March 3, 2026 — Leads & Copy — BioHarvest Sciences Inc. (NASDAQ: BHST) announced that its management has been invited to the 38th Annual Roth Conference, scheduled for March 22-24, 2026, in Dana Point, CA. The company is a pioneer in its patented Botanical Synthesis technology platform.
CEO Ilan Sobel is scheduled to hold one-on-one meetings with institutional investors during the conference.
The 38th Annual Roth Conference for Growth Companies will take place at The Ritz-Carlton Laguna Niguel.
Sobel stated that the invitation to the Roth Conference presents a high-profile opportunity to highlight BioHarvest to sophisticated investors. He noted that a successful Q4 2025 financing round has positioned the company to accelerate growth in its CDMO and Consumer Product businesses. The company currently has over 85,000 direct customers on the Product side and established CDMO research partnerships.
Sobel added that the company is well-positioned to achieve significant growth milestones in 2026, by leveraging novel plant-based compounds in its mission to improve human health and wellness.
Registration is required for conference participation. Those interested in scheduling a meeting with management can contact info@bioharvest.com.
BioHarvest Sciences Inc. leverages its patented technology platform to grow plant-based compounds without the need to grow the underlying plant. The company develops science-based and clinically proven therapeutic solutions within two business verticals: a contract development and manufacturing organization (CDMO) and proprietary nutraceutical health and wellness products, including dietary supplements.
Source: BioHarvest Sciences Inc.
